This company listing is no longer active
A2MR34 Stock Overview
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Amyris, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.08 |
| 52 Week High | US$23.90 |
| 52 Week Low | US$0.55 |
| Beta | 1.19 |
| 1 Month Change | -78.14% |
| 3 Month Change | -61.29% |
| 1 Year Change | -94.01% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| A2MR34 | BR Chemicals | BR Market | |
|---|---|---|---|
| 7D | -16.9% | -1.4% | -1.0% |
| 1Y | -94.0% | -11.5% | 12.7% |
Return vs Industry: A2MR34 underperformed the BR Chemicals industry which returned -25.1% over the past year.
Return vs Market: A2MR34 underperformed the BR Market which returned -5.7% over the past year.
Price Volatility
| A2MR34 volatility | |
|---|---|
| A2MR34 Average Weekly Movement | 37.1% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.3% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: A2MR34's share price has been volatile over the past 3 months.
Volatility Over Time: A2MR34's weekly volatility has increased from 23% to 37% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 1,598 | Han Kieftenbeld | amyris.com |
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names.
Amyris, Inc. Fundamentals Summary
| A2MR34 fundamental statistics | |
|---|---|
| Market cap | R$146.45m |
| Earnings (TTM) | -R$3.06b |
| Revenue (TTM) | R$1.34b |
0.1x
P/S Ratio0.0x
P/E RatioIs A2MR34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2MR34 income statement (TTM) | |
|---|---|
| Revenue | US$268.22m |
| Cost of Revenue | US$369.78m |
| Gross Profit | -US$101.55m |
| Other Expenses | US$512.99m |
| Earnings | -US$614.55m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.66 |
| Gross Margin | -37.86% |
| Net Profit Margin | -229.12% |
| Debt/Equity Ratio | -145.2% |
How did A2MR34 perform over the long term?
See historical performance and comparison